Neil William Aubuchon
CIK: 0002106781
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VKTX
Viking Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Aubuchon Neil William
Aubuchon Neil William (SEC CIK 0002106781) files insider reports with the SEC as Chief Commercial Officer of Viking Therapeutics, Inc. (VKTX).
Signal8 holds 3 ownership filings by Aubuchon Neil William (1 Form 3, 2 Form 4), filed between Jan 26, 2026 and Mar 10, 2026. Those filings report 2 transactions, from Jan 12, 2026 to Mar 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aubuchon Neil William's filings is in SAN DIEGO, CA.
Recent filings by Aubuchon Neil William
Other insiders filing for Viking Therapeutics, Inc. (VKTX)
- Kelly-Gemmell Dorothy Elizabeth, Director
- Lian Brian, President & CEO
- ZANTE GREG, Chief Financial Officer
- Mancini Marianna, Chief Operating Officer
- Chen Hubert C, Chief Medical Officer
- SINGLETON J MATTHEW, Director